Made in USA

Independently verifiedCertified

CJC / Ipamorelin · 5mg + 5mg

Purity (HPLC)>98%

LabVantage Analytical

Tested28 Jun 2026

Batch —·

Heavy metalsEndotoxinsMicrobialSolvents

View full COA

In stock

CJC / Ipamorelin

Name: CJC / Ipamorelin
Brand: AXOS
Availability: InStock

$99

GHRH analog / GHS receptor agonist — dual-receptor GH axis research

Buy 1, Get 1 Free · auto-applied

Add 2+ items to cart to activate the discount

VISAAMEXPayPal

Secure, encrypted checkout

Independently verifiedCertified

CJC / Ipamorelin · 5mg + 5mg

Purity (HPLC)>98%

LabVantage Analytical

Tested28 Jun 2026

Batch —·

Heavy metalsEndotoxinsMicrobialSolvents

View full COA

Frequently bought together

Researchers usually add these to complete the protocol.

BAC Water · 3ml

Essential · Extras

GHK-CU · 50mg

Recovery

$39

Melanotan 2 · 10mg

Tanning

$49

Add all (3)$97

Certificate of analysis

Every vial ships with its own report

We don't publish a brand-wide spec sheet and call it a “COA.” The certificate you receive references the actual lot number stamped on your vial — with the raw chromatograms attached.

Lot-specific HPLC purity + LC-MS identity
Raw chromatogram + mass confirmation attached
Signed off by the lab's Principal Chemist
Permanent archive — searchable by lot ID

View all lab reports

Reference reportView All Live Reports

Vantage Analytical

Independent analytical lab

Certificate of Analysis

RESULT · PASS

ProductCJC / Ipamorelin · 5mg + 5mg

Lot / batch—

Reported28 Jun 2026

MethodHPLC-UV + LC-MS

AppearanceWhite lyophilized powder

ClientSolace Peptides

Analytical results

Identity (LC-MS)1419.5 DaPASS

Purity (HPLC-UV)>98%PASS

Net content10.2 mgPASS

Endotoxin (LAL)< 0.05 EU/mgPASS

Heavy metals (ICP-MS)< 10 ppmPASS

Residual solventsBelow LOQPASS

HPLC Chromatogram

Purity >98%

Chemist verifiedDr. E. Hartley

Know your compound

What is CJC / Ipamorelin?

CJC-1295 is a synthetic GHRH analog that extends endogenous growth hormone release by binding GHRHR on somatotroph cells; Ipamorelin is a selective GHS-R1a agonist that stimulates GH release independently through the ghrelin receptor. Together they engage two complementary receptor populations on the same secretory pathway.

The combination is studied because co-administration produces IGF-1 elevation beyond what either peptide achieves alone — a synergistic effect documented in CJC-1295 clinical trials by Teichman et al. Ipamorelin's selectivity profile, specifically its dissociation from cortisol, prolactin, and appetite signaling in preclinical models, makes it a reference compound for interrogating GH-axis specificity.

Synergistic IGF-1 elevation beyond either peptide alone in clinical CJC-1295 trials (Teichman et al.)
Ipamorelin elicits GH release without co-elevating cortisol or prolactin in preclinical models (Raun et al.)
Dual-receptor engagement preserves pulsatile GH release architecture in combination studies

Lot-specific COAEvery lot ships with an HPLC Certificate of Analysis and mass-spectrometry identity confirmation.

Institutional fulfilmentShipped to verified institutional addresses with full analytical documentation.

Lot-specific COA: Every lot ships with an HPLC Certificate of Analysis and mass-spectrometry identity confirmation.
Institutional fulfilment: Shipped to verified institutional addresses with full analytical documentation.

For research use only — not for human or veterinary use.

The research

What the research actually found

The published findings behind this compound — the headline numbers, in plain terms, each cited to source. Preclinical results are directional (animal / in-vitro) and shown for context, not as therapeutic claims.

Published research on the reference compound class. Provided for scientific context only — not a claim about the product supplied.

IGF-1 synergyClinical

In CJC-1295 clinical trials by Teichman et al., combining CJC-1295 with a GH secretagogue produced IGF-1 elevations that exceeded what either peptide achieved alone — a synergistic pattern not seen with monotherapy.

Teichman et al. CJC-1295 clinical trials; Sports Medicine 2026 · PMID 41966639

CJC-1295 alone↑ moderate

Ipamorelin alone↑ moderate

CJC-1295 + Ipamorelin↑ beyond either alone

Relative IGF-1 elevation — directional only; no exact figures extracted from grounded sources. CJC-1295 clinical trials, Teichman et al.

Hormonal selectivityPreclinical

In preclinical animal models (Raun et al.), Ipamorelin stimulated GH release without measurably raising cortisol or prolactin — distinguishing it from less-selective GH secretagogues that co-activate stress and lactation pathways.

vs broader secretagogues that raise cortisol & prolactin

GH release↑ robust

Cortisolno co-elevation

Prolactinno co-elevation

Directional only — preclinical animal models, Raun et al. Quantitative values not available in grounded sources.

Raun et al. (preclinical); Am J Sports Medicine 2026 · PMID 41476424

Human evidence gapClinical

Two independent 2026 systematic reviews concluded that while mechanistic and preclinical data for CJC-1295 / Ipamorelin are established, controlled human clinical trial evidence for this combination remains limited — underscoring its research-use-only status.

Preclinical / mechanistic evidencesubstantialControlled human trialslimited

Qualitative evidence-base mapping — Sports Medicine 2026 & Frontiers in Aging 2026 systematic reviews.

Sports Medicine 2026 · PMID 41966639; Frontiers in Aging 2026 · PMID 42021992

CJC / Ipamorelin (5mg + 5mg) — molecular specimen

GHRHR activationGHRH analog pathway

GHS-R1a agonismghrelin receptor pathway

IGF-1 elevationsomatotropic axis output

Mechanism

How CJC / Ipamorelin works

CJC-1295 and Ipamorelin are studied to act through two distinct receptor systems that converge on pituitary somatotrophs, with downstream signaling propagated via IGF-1.

GHRHR activationGHRH analog pathway

CJC-1295 binds the growth hormone-releasing hormone receptor (GHRHR) on anterior pituitary somatotrophs, amplifying the amplitude of endogenous GH release pulses in preclinical and early clinical models.

GHS-R1a agonismghrelin receptor pathway

Ipamorelin acts as a selective agonist at the ghrelin receptor (GHS-R1a), stimulating GH secretion through a pathway independent of GHRHR and, in preclinical studies, without co-activating the cortisol or prolactin axes.

IGF-1 elevationsomatotropic axis output

Dual-receptor engagement is associated in research models with synergistic downstream elevation of IGF-1, the principal mediator of systemic growth hormone action, studied as a functional readout of combined GHRHR and GHS-R1a co-stimulation.

For research use only. Mechanisms described reflect published preclinical and clinical literature.

The process

How every batch is verified

01
Synthesized
Produced under controlled manufacturing with documented, repeatable processes.
02
HPLC purity
An independent lab reports the exact purity of every lot — a number, never a 'passes'.
03
Mass-spec identity
Molecular weight confirms the exact sequence is what the label says.
04
COA published
The certificate is posted to the open library, by lot, before the vial ships.

Verified researchers

Reviewed by people who test it themselves

Best sellers

Researchers reach for these

Best seller

5 Amino 1MQ

50mg

5.0

≥98% HPLC

$89

Best seller

BAC Water

10ml

5.0

$19

BPC-157

10mg

5.0

≥98% HPLC

$69

BPC-157 + TB-500

10mg + 10mg

5.0

≥98% HPLC

$119

CJC-1295 with DAC

5mg

5.0

≥98% HPLC

$79

CJC-1295 without DAC

5mg

5.0

>98% HPLC

$69

FAQ

Frequently asked

Common questions about CJC / Ipamorelin

The COA guarantee

>98% pure — or your money back.

Have any lot independently re-tested. If the results don't match the published certificate, we refund the order in full — no returns, no questions.

Order with cover

Third-party tested

An independent, accredited lab — no commercial interest in the result.

A COA on every lot

A lot-specific certificate ships with each vial, archived by batch.

Test it yourself → refund

Re-test any batch at any lab. A mismatch is a full refund.

Every vial ships with its own report

We don't publish a brand-wide spec sheet and call it a “COA.” The certificate you receive references the actual lot number stamped on your vial — with the raw chromatograms attached.

Lot-specific HPLC purity + LC-MS identity

Raw chromatogram + mass confirmation attached

Signed off by the lab's Principal Chemist

Permanent archive — searchable by lot ID

View all lab reports

What is CJC / Ipamorelin?

Synergistic IGF-1 elevation beyond either peptide alone in clinical CJC-1295 trials (Teichman et al.)

Ipamorelin elicits GH release without co-elevating cortisol or prolactin in preclinical models (Raun et al.)

Dual-receptor engagement preserves pulsatile GH release architecture in combination studies

How CJC / Ipamorelin works

CJC-1295 and Ipamorelin are studied to act through two distinct receptor systems that converge on pituitary somatotrophs, with downstream signaling propagated via IGF-1.